Mauro Gitto on Comparison of Paclitaxel-coated Balloons with Urea or Iopromide
Mauro Gitto, Interventional Cardiologist at Humanitas Research Hospital, shared on LinkedIn:
”Our latest article comparing two contemporary paclitaxel-coated balloons (urea-coated Prevail vs iopromide-coated Sequent Please) for the treatment of both de novo and ISR lesions.
As evidence in support of DCB-based PCI grows, more and more device-comparing studies are needed!
Full text here.”
Read the full article here.
Article: Paclitaxel-coated balloon with urea or iopromide as the excipient for treatment of coronary artery disease
Authors: Mauro Gitto, Francesco Tartaglia, Pier Pasquale Leone, Gianmaria Calamita, Alessandro Gabrielli, Leon Gramss, Marco Luciano Rossi, Damiano Regazzoli, Gabriele Gasparini, Ottavia Cozzi, Bernhard Reimers, Giulio Giuseppe Stefanini, Antonio Mangieri, Azeem Latib, Antonio Colombo
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation